Alan Kaye, MD, PhD: Treating Pain During COVID-19

Video

Leveraging telemedicine during COVID-19.

Treating pain during the coronavirus disease 2019 (COVID-19) pandemic has been difficult.

Unless there was an unusual emergency, interventional pain procedures were considered elective, Alan Kaye, MD, PhD, of LSU Health School of Medicine, told HCPLive® in a recent interview. Most were canceled because of concerns about supplies and the doctors did not want patients to get exposed.

“Pain medicine has gone through radical changes with telemedicine becoming the norm,” Kaye said.

The pandemic has been a serious challenge, he added.

Research has been published touching on all of the issues related to treating pain during COVID-19.

While pain doctors and rheumatologists alike have needed to shift its focus and use telemedicine to treat patients, some rheumatologists may have already been leveraging the technology for consults with patients.

“Every doctor and every person in America and probably worldwide have been affected by COVID,” Kaye said. He added it should not be surprising the Congress of Clinical Rheumatology East 2020 meeting was taking place virtually over laptops.

Hear more from Kaye in the video interview clip posted above.

Related Videos
Why Are Adult ADHD Cases Climbing?
How Psoriatic Arthritis Presentation, Treatment Has Evolved
Optimizing Diabetes Therapies with New Classifications
Anthony Lembo, MD | Credit: Cleveland Clinic
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Elizabeth Aby, MD | Credit: Minnesota Health Fairview
Prashant Singh, MD | Credit: University of Michigan
Noa Krugliak Cleveland, MD | Credit: University of Chicago
© 2024 MJH Life Sciences

All rights reserved.